A rapid roundup of pathology and lab medicine news
Michael Schubert | | Quick Read
CRISPR for COVID-19
The demand for rapid COVID-19 screening is ravenous – especially in settings without the necessary equipment and resources to conduct metagenomic next-generation sequencing or RT-PCR. To address this gap, researchers have developed a new test that uses CRISPR technology to provide rapid, sensitive COVID-19 diagnosis (1).
New research reveals distinct differences in the anti-gluten antibodies of patients with celiac disease and those with non-celiac gluten sensitivity (2). Whereas the former experience a strong, sustained primary B cell response, the latter evidence similar antibody levels, but less inflammation.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine